Arnold Lippa Insider Trading $RSPI RespireRx Pharmaceuticals Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Arnold Lippa.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Arnold Lippa. Arnold Lippa is Chairman, CEO & President in RespireRx Pharmaceuticals Inc. ($RSPI) and Exec Chairman, CSO in RespireRx Pharmaceuticals Inc. ($RSPI) and Exec. Chairman & CSO in RespireRx Pharmaceuticals Inc. ($RSPI) and Exec. Chairman and CSO in RespireRx Pharmaceuticals Inc. ($RSPI) and Exec. Chairman, CEO & CSO in RespireRx Pharmaceuticals Inc. ($RSPI) and Exec. Chairman, CEO, CSO in RespireRx Pharmaceuticals Inc. ($RSPI) and Executive Chairman & CSO in RespireRx Pharmaceuticals Inc. ($RSPI) and Executive Chairman and CSO in RespireRx Pharmaceuticals Inc. ($RSPI) and Director in Euthymics Bioscience Inc ($DOVP) and Director in ContraVir Pharmaceuticals, Inc. ($CTRV).
Arnold Lippa in RespireRx Pharmaceuticals Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Arnold Lippa: Exec. Chairman & CSO, Exec. Chairman, CEO & CSO, Exec. Chairman, CEO, CSO, Exec Chairman, CSO, Executive Chairman & CSO, Executive Chairman and CSO, Exec. Chairman and CSO, Chairman, CEO & President
Holdings: 4,500,598 shares
Current Value: $17,552,332
Latest Transaction: Oct 02 2020
$RSPI Market Capitalization: $7.87M
$RSPI Previous Close: $3.90
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Arnold Lippa in RespireRx Pharmaceuticals Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, DOVP, HEPA, RSPI
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 02 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman & CS ... | Option Exercise | G | 0.01 | 100 | 1 | 0 | |
| Oct 02 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman & CS ... | Option Exercise | G | 0.01 | 100 | 1 | 0 | |
| Oct 02 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman & CS ... | Option Exercise | G | 0.01 | 100 | 1 | 0 | |
| Oct 02 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman & CS ... | Option Exercise | G | 0.01 | 100 | 1 | 0 | |
| Oct 02 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman & CS ... | Option Exercise | J | 0.01 | 100 | 1 | 100 | |
| Oct 02 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman & CS ... | Option Exercise | J | 0.01 | 100 | 1 | 100 | |
| Jul 15 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman, CEO ... | Option Exercise | G | 0.01 | 600 | 4 | 0 | |
| Jul 15 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman, CEO ... | Option Exercise | G | 0.01 | 600 | 4 | 0 | |
| Jul 15 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman, CEO ... | Option Exercise | J | 0.01 | 600 | 4 | 600 | |
| Jul 15 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman, CEO ... | Option Exercise | G | 0.01 | 600 | 4 | 0 | |
| Jul 15 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman, CEO ... | Option Exercise | G | 0.01 | 600 | 4 | 0 | |
| Jul 15 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman, CEO ... | Option Exercise | J | 0.01 | 600 | 4 | 600 | |
| Mar 24 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman, CEO ... | Gift | G | 0.00 | 4,500,000 | 0 | 598 | 4.5 M to 598 (-99.99 %) |
| Mar 24 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman, CEO ... | Buy | J | 0.00 | 4,500,000 | 0 | 4,500,598 | 598 to 4.5 M (+752,508.36 %) |
| Sep 14 2018 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec Chairman, CSO | Option Exercise | G | 1.58 | 47,620 | 75,002 | 0 | |
| Sep 14 2018 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec Chairman, CSO | Option Exercise | P | 1.58 | 47,620 | 75,002 | 47,620 | |
| Sep 14 2018 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec Chairman, CSO | Gift | G | 0.00 | 47,620 | 0 | 0 | 47.6 K to 0 (-100.00 %) |
| Sep 14 2018 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec Chairman, CSO | Buy | P | 0.00 | 47,620 | 0 | 47,620 | 0 to 47.6 K |
| Dec 12 2017 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec Chairman, CSO | Option Exercise | G | 1.45 | 559,595 | 811,413 | 0 | |
| Dec 12 2017 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec Chairman, CSO | Option Exercise | J | 1.45 | 559,595 | 811,413 | 559,595 | |
| Jul 05 2017 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Executive Chairman ... | Option Exercise | J | 2.00 | 50,000 | 100,000 | 0 | |
| Jul 05 2017 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Executive Chairman ... | Option Exercise | A | 2.00 | 50,000 | 100,000 | 50,000 | |
| Jan 20 2017 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Executive Chairman ... | Option Exercise | J | 3.90 | 50,000 | 195,000 | 0 | |
| Jan 20 2017 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Executive Chairman ... | Option Exercise | A | 3.90 | 50,000 | 195,000 | 50,000 | |
| Jun 20 2016 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Executive Chairman ... | Option Exercise | J | 0.02 | 24,000,000 | 544,800 | 0 | |
| Jun 20 2016 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Executive Chairman ... | Option Exercise | J | 0.02 | 10,000,000 | 197,000 | 0 | |
| Jun 20 2016 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Executive Chairman ... | Option Exercise | J | 0.03 | 15,000,000 | 375,000 | 0 | |
| Apr 04 2016 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Executive Chairman ... | Option Exercise | A | 0.02 | 24,000,000 | 544,800 | 24,000,000 | |
| Apr 04 2016 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Executive Chairman ... | Option Exercise | J | 0.02 | 3,350,319 | 52,600 | 3,350,319 | |
| Aug 20 2015 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman and ... | Option Exercise | A | 0.02 | 10,000,000 | 197,000 | 10,000,000 | |
| Jul 06 2015 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Chairman, CEO & Pre ... | Option Exercise | A | 0.03 | 15,000,000 | 375,000 | 15,000,000 |
Page: 1